Cargando…

Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review

INTRODUCTION: Racial discrimination has been identified as a risk factor for cardiometabolic diseases, the leading cause of morbidity and mortality among racial/ethnic minority groups; however, there is no synthesis of current knowledge on the association between discrimination and cardiometabolic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbonlahor, Osayande, DeJarnett, Natasha, Hart, Joy L., Bhatnagar, Aruni, McLeish, Alison C., Walker, Kandi L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044132/
https://www.ncbi.nlm.nih.gov/pubmed/36976513
http://dx.doi.org/10.1007/s40615-023-01561-1
_version_ 1784913299255590912
author Agbonlahor, Osayande
DeJarnett, Natasha
Hart, Joy L.
Bhatnagar, Aruni
McLeish, Alison C.
Walker, Kandi L.
author_facet Agbonlahor, Osayande
DeJarnett, Natasha
Hart, Joy L.
Bhatnagar, Aruni
McLeish, Alison C.
Walker, Kandi L.
author_sort Agbonlahor, Osayande
collection PubMed
description INTRODUCTION: Racial discrimination has been identified as a risk factor for cardiometabolic diseases, the leading cause of morbidity and mortality among racial/ethnic minority groups; however, there is no synthesis of current knowledge on the association between discrimination and cardiometabolic diseases. The objective of this systematic review was to summarize evidence linking racial/ethnic discrimination and cardiometabolic diseases. METHODS: The review was conducted based on studies identified via electronic searches of 5 databases (PubMed, Google Scholar, WorldWideScience.org, ResearchGate and Microsoft Academic) using terms related to discrimination and cardiometabolic disease. RESULTS: Of the 123 eligible studies included in the review, 87 were cross-sectional, 25 longitudinal, 8 quasi-experimental, 2 randomized controlled trials and 1 case–control. Cardiometabolic disease outcomes discussed were hypertension (n = 46), cardiovascular disease (n = 40), obesity (n = 12), diabetes (n = 11), metabolic syndrome (n = 9), and chronic kidney disease (n = 5). Although a variety of discrimination measures was employed across the studies, the Everyday Discrimination Scale was used most often (32.5%). African Americans/Blacks were the most frequently studied racial/ethnic group (53.1%), and American Indians the least (0.02%). Significant associations between racial/ethnic discrimination and cardiometabolic disease were found in 73.2% of the studies. DISCUSSION: Racial/ethnic discrimination is positively associated with increased risk of cardiometabolic disease and higher levels of cardiometabolic biomarkers. Identifying racial/ethnic discrimination as a potential key contributor to the health inequities associated with cardiometabolic diseases is important for addressing the significant burden borne by racial/ethnic minorities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40615-023-01561-1.
format Online
Article
Text
id pubmed-10044132
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100441322023-03-28 Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review Agbonlahor, Osayande DeJarnett, Natasha Hart, Joy L. Bhatnagar, Aruni McLeish, Alison C. Walker, Kandi L. J Racial Ethn Health Disparities Article INTRODUCTION: Racial discrimination has been identified as a risk factor for cardiometabolic diseases, the leading cause of morbidity and mortality among racial/ethnic minority groups; however, there is no synthesis of current knowledge on the association between discrimination and cardiometabolic diseases. The objective of this systematic review was to summarize evidence linking racial/ethnic discrimination and cardiometabolic diseases. METHODS: The review was conducted based on studies identified via electronic searches of 5 databases (PubMed, Google Scholar, WorldWideScience.org, ResearchGate and Microsoft Academic) using terms related to discrimination and cardiometabolic disease. RESULTS: Of the 123 eligible studies included in the review, 87 were cross-sectional, 25 longitudinal, 8 quasi-experimental, 2 randomized controlled trials and 1 case–control. Cardiometabolic disease outcomes discussed were hypertension (n = 46), cardiovascular disease (n = 40), obesity (n = 12), diabetes (n = 11), metabolic syndrome (n = 9), and chronic kidney disease (n = 5). Although a variety of discrimination measures was employed across the studies, the Everyday Discrimination Scale was used most often (32.5%). African Americans/Blacks were the most frequently studied racial/ethnic group (53.1%), and American Indians the least (0.02%). Significant associations between racial/ethnic discrimination and cardiometabolic disease were found in 73.2% of the studies. DISCUSSION: Racial/ethnic discrimination is positively associated with increased risk of cardiometabolic disease and higher levels of cardiometabolic biomarkers. Identifying racial/ethnic discrimination as a potential key contributor to the health inequities associated with cardiometabolic diseases is important for addressing the significant burden borne by racial/ethnic minorities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40615-023-01561-1. Springer International Publishing 2023-03-28 /pmc/articles/PMC10044132/ /pubmed/36976513 http://dx.doi.org/10.1007/s40615-023-01561-1 Text en © W. Montague Cobb-NMA Health Institute 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Agbonlahor, Osayande
DeJarnett, Natasha
Hart, Joy L.
Bhatnagar, Aruni
McLeish, Alison C.
Walker, Kandi L.
Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title_full Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title_fullStr Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title_full_unstemmed Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title_short Racial/Ethnic Discrimination and Cardiometabolic Diseases: A Systematic Review
title_sort racial/ethnic discrimination and cardiometabolic diseases: a systematic review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044132/
https://www.ncbi.nlm.nih.gov/pubmed/36976513
http://dx.doi.org/10.1007/s40615-023-01561-1
work_keys_str_mv AT agbonlahorosayande racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview
AT dejarnettnatasha racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview
AT hartjoyl racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview
AT bhatnagararuni racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview
AT mcleishalisonc racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview
AT walkerkandil racialethnicdiscriminationandcardiometabolicdiseasesasystematicreview